GSK
4 years ago ⋅ English ⋅ 6 min read
Newsroom
GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease

For media and investors onlyIssued: 5 November, London UK- Late-breaking data from the daprodustat ASCEND-ND and ASCEND-D trials at the American Society of Nephrology’s Kidney Wee... Read More
GSK
4 years ago ⋅ English ⋅ 19 min read
Newsroom
ViiV Healthcare presents positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine) can be implemented successfully in a variety of European healthcare settings

­ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today presented... Read More
GSK
4 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK delivers strong Q3 sales of £9.1 billion +5% AER, +10% CER Total EPS 23.3p -7% AER, +3% CER; Adjusted EPS 36.6p +3% AER, +10% CER 2021 full year EPS guidance improved

For media and investors onlyFull results announcement (PDF)Download the Q3 2021 results announcementQ3 2021 results announcement (PDF, 1.1MB)Sales growth across Pharmaceuticals, Vaccine... Read More
GSK
4 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director

For media and investors onlyIssued: 27 October, London UK- Appointment further strengthens Board scientific capabilities, including in genetics which is central to GSK’s R&D a... Read More
GSK
4 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK Consumer Healthcare solidifies commitment to pharmacists with 3-year Pharmacist Support Programme

GSK Consumer Healthcare today unveils a three-year programme to support the pharmacy profession with additional practical resources, mental health provisions and proposed policy changes... Read More
GSK
4 years ago ⋅ English ⋅ 5 min read
Newsroom
US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for immunocompromised adults aged 19 and up

For media and investors onlyIssued: Philadelphia, LondonGlaxoSmithKline plc today announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Im... Read More